nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—ABCB1—hematologic cancer	0.0784	1	CbGaD
Promethazine—CYP2B6—Thiotepa—hematologic cancer	0.0346	0.0731	CbGbCtD
Promethazine—CYP2C9—Bexarotene—hematologic cancer	0.022	0.0466	CbGbCtD
Promethazine—ABCB1—Lenalidomide—hematologic cancer	0.0214	0.0452	CbGbCtD
Promethazine—CYP2B6—Ifosfamide—hematologic cancer	0.0196	0.0415	CbGbCtD
Promethazine—CYP2D6—Lomustine—hematologic cancer	0.0187	0.0396	CbGbCtD
Promethazine—CYP2C9—Idarubicin—hematologic cancer	0.0183	0.0386	CbGbCtD
Promethazine—CYP2B6—Nilotinib—hematologic cancer	0.017	0.036	CbGbCtD
Promethazine—CYP2D6—Idarubicin—hematologic cancer	0.0167	0.0353	CbGbCtD
Promethazine—CYP2D6—Hydroxyurea—hematologic cancer	0.0142	0.03	CbGbCtD
Promethazine—CYP2C9—Bortezomib—hematologic cancer	0.0135	0.0286	CbGbCtD
Promethazine—ABCB1—Daunorubicin—hematologic cancer	0.0125	0.0265	CbGbCtD
Promethazine—CYP2D6—Bortezomib—hematologic cancer	0.0124	0.0261	CbGbCtD
Promethazine—ABCB1—Alitretinoin—hematologic cancer	0.0123	0.026	CbGbCtD
Promethazine—CYP2C9—Thalidomide—hematologic cancer	0.0118	0.0249	CbGbCtD
Promethazine—CYP2B6—Irinotecan—hematologic cancer	0.0117	0.0248	CbGbCtD
Promethazine—CYP2C9—Teniposide—hematologic cancer	0.0112	0.0237	CbGbCtD
Promethazine—CYP2C9—Ifosfamide—hematologic cancer	0.0104	0.0219	CbGbCtD
Promethazine—CYP2C9—Imatinib—hematologic cancer	0.0099	0.0209	CbGbCtD
Promethazine—ABCB1—Imatinib—hematologic cancer	0.00961	0.0203	CbGbCtD
Promethazine—CYP2B6—Cisplatin—hematologic cancer	0.00954	0.0202	CbGbCtD
Promethazine—CYP2D6—Imatinib—hematologic cancer	0.00905	0.0191	CbGbCtD
Promethazine—CYP2C9—Nilotinib—hematologic cancer	0.009	0.019	CbGbCtD
Promethazine—ABCB1—Nilotinib—hematologic cancer	0.00873	0.0185	CbGbCtD
Promethazine—ABCB1—Vinorelbine—hematologic cancer	0.00866	0.0183	CbGbCtD
Promethazine—CYP2D6—Nilotinib—hematologic cancer	0.00823	0.0174	CbGbCtD
Promethazine—CYP2D6—Vinorelbine—hematologic cancer	0.00816	0.0173	CbGbCtD
Promethazine—ABCB1—Dasatinib—hematologic cancer	0.00772	0.0163	CbGbCtD
Promethazine—CYP2B6—Dexamethasone—hematologic cancer	0.00771	0.0163	CbGbCtD
Promethazine—ABCB1—Mitoxantrone—hematologic cancer	0.00762	0.0161	CbGbCtD
Promethazine—ABCB1—Betamethasone—hematologic cancer	0.00679	0.0144	CbGbCtD
Promethazine—ABCB1—Gemcitabine—hematologic cancer	0.00673	0.0142	CbGbCtD
Promethazine—ABCB1—Prednisolone—hematologic cancer	0.0067	0.0142	CbGbCtD
Promethazine—CYP2B6—Doxorubicin—hematologic cancer	0.00639	0.0135	CbGbCtD
Promethazine—ABCB1—Prednisone—hematologic cancer	0.00633	0.0134	CbGbCtD
Promethazine—ABCB1—Irinotecan—hematologic cancer	0.006	0.0127	CbGbCtD
Promethazine—ABCB1—Vinblastine—hematologic cancer	0.00534	0.0113	CbGbCtD
Promethazine—ABCB1—Vincristine—hematologic cancer	0.00525	0.0111	CbGbCtD
Promethazine—CYP2C9—Cisplatin—hematologic cancer	0.00504	0.0107	CbGbCtD
Promethazine—CYP2D6—Vinblastine—hematologic cancer	0.00503	0.0106	CbGbCtD
Promethazine—ABCB1—Cisplatin—hematologic cancer	0.00489	0.0103	CbGbCtD
Promethazine—ABCB1—Etoposide—hematologic cancer	0.00481	0.0102	CbGbCtD
Promethazine—HRH4—hematopoietic system—hematologic cancer	0.00468	0.116	CbGeAlD
Promethazine—CYP2C9—Dexamethasone—hematologic cancer	0.00407	0.00861	CbGbCtD
Promethazine—ABCB1—Dexamethasone—hematologic cancer	0.00395	0.00836	CbGbCtD
Promethazine—CYP2D6—Dexamethasone—hematologic cancer	0.00372	0.00787	CbGbCtD
Promethazine—ABCB1—Doxorubicin—hematologic cancer	0.00328	0.00693	CbGbCtD
Promethazine—ABCB1—Methotrexate—hematologic cancer	0.00318	0.00672	CbGbCtD
Promethazine—HRH4—blood—hematologic cancer	0.0031	0.0769	CbGeAlD
Promethazine—CYP2D6—Doxorubicin—hematologic cancer	0.00309	0.00653	CbGbCtD
Promethazine—HRH4—bone marrow—hematologic cancer	0.003	0.0744	CbGeAlD
Promethazine—CHRM4—testis—hematologic cancer	0.00132	0.0326	CbGeAlD
Promethazine—CALM2—hematopoietic system—hematologic cancer	0.00103	0.0255	CbGeAlD
Promethazine—CALM1—hematopoietic system—hematologic cancer	0.00102	0.0254	CbGeAlD
Promethazine—ADRA1A—hematopoietic system—hematologic cancer	0.000964	0.0239	CbGeAlD
Promethazine—CALM3—blood—hematologic cancer	0.000867	0.0215	CbGeAlD
Promethazine—CALM3—bone marrow—hematologic cancer	0.000839	0.0208	CbGeAlD
Promethazine—CALM2—gonad—hematologic cancer	0.000781	0.0194	CbGeAlD
Promethazine—CALM1—gonad—hematologic cancer	0.000778	0.0193	CbGeAlD
Promethazine—CYP2B6—hematopoietic system—hematologic cancer	0.000764	0.0189	CbGeAlD
Promethazine—CALM3—lung—hematologic cancer	0.00076	0.0188	CbGeAlD
Promethazine—CYP2C9—hematopoietic system—hematologic cancer	0.000757	0.0188	CbGeAlD
Promethazine—HRH1—hematopoietic system—hematologic cancer	0.000746	0.0185	CbGeAlD
Promethazine—CALM3—testis—hematologic cancer	0.000717	0.0178	CbGeAlD
Promethazine—CHRM1—lung—hematologic cancer	0.000681	0.0169	CbGeAlD
Promethazine—CALM2—blood—hematologic cancer	0.000681	0.0169	CbGeAlD
Promethazine—CALM1—blood—hematologic cancer	0.000678	0.0168	CbGeAlD
Promethazine—CALM2—bone marrow—hematologic cancer	0.000659	0.0163	CbGeAlD
Promethazine—CALM1—bone marrow—hematologic cancer	0.000656	0.0163	CbGeAlD
Promethazine—ADRA1A—blood—hematologic cancer	0.000639	0.0158	CbGeAlD
Promethazine—HTR2A—hematopoietic system—hematologic cancer	0.000623	0.0154	CbGeAlD
Promethazine—CALM2—lung—hematologic cancer	0.000597	0.0148	CbGeAlD
Promethazine—CALM1—lung—hematologic cancer	0.000594	0.0147	CbGeAlD
Promethazine—CYP2B6—gonad—hematologic cancer	0.000581	0.0144	CbGeAlD
Promethazine—CHRM3—testis—hematologic cancer	0.000575	0.0143	CbGeAlD
Promethazine—CYP2D6—hematopoietic system—hematologic cancer	0.000568	0.0141	CbGeAlD
Promethazine—CALM2—testis—hematologic cancer	0.000563	0.014	CbGeAlD
Promethazine—CALM1—testis—hematologic cancer	0.000561	0.0139	CbGeAlD
Promethazine—DRD2—lung—hematologic cancer	0.000549	0.0136	CbGeAlD
Promethazine—CALM3—lymph node—hematologic cancer	0.00052	0.0129	CbGeAlD
Promethazine—DRD2—testis—hematologic cancer	0.000518	0.0128	CbGeAlD
Promethazine—CYP2B6—blood—hematologic cancer	0.000506	0.0125	CbGeAlD
Promethazine—CYP2C9—blood—hematologic cancer	0.000501	0.0124	CbGeAlD
Promethazine—HTR2A—gonad—hematologic cancer	0.000474	0.0117	CbGeAlD
Promethazine—CYP2B6—lung—hematologic cancer	0.000444	0.011	CbGeAlD
Promethazine—HRH1—lung—hematologic cancer	0.000433	0.0107	CbGeAlD
Promethazine—CYP2B6—testis—hematologic cancer	0.000419	0.0104	CbGeAlD
Promethazine—HTR2A—blood—hematologic cancer	0.000413	0.0102	CbGeAlD
Promethazine—HRH1—testis—hematologic cancer	0.000409	0.0101	CbGeAlD
Promethazine—ABCB1—hematopoietic system—hematologic cancer	0.000408	0.0101	CbGeAlD
Promethazine—CALM2—lymph node—hematologic cancer	0.000408	0.0101	CbGeAlD
Promethazine—CALM1—lymph node—hematologic cancer	0.000406	0.0101	CbGeAlD
Promethazine—CYP2D6—blood—hematologic cancer	0.000376	0.00932	CbGeAlD
Promethazine—HTR2A—lung—hematologic cancer	0.000362	0.00897	CbGeAlD
Promethazine—HTR2A—testis—hematologic cancer	0.000341	0.00846	CbGeAlD
Promethazine—CYP2D6—testis—hematologic cancer	0.000311	0.00771	CbGeAlD
Promethazine—ABCB1—gonad—hematologic cancer	0.00031	0.0077	CbGeAlD
Promethazine—HRH1—lymph node—hematologic cancer	0.000296	0.00735	CbGeAlD
Promethazine—ABCB1—blood—hematologic cancer	0.000271	0.00671	CbGeAlD
Promethazine—ABCB1—bone marrow—hematologic cancer	0.000262	0.00649	CbGeAlD
Promethazine—ABCB1—lung—hematologic cancer	0.000237	0.00588	CbGeAlD
Promethazine—ABCB1—testis—hematologic cancer	0.000224	0.00555	CbGeAlD
Promethazine—Acepromazine—SLC22A1—hematologic cancer	0.00019	0.0932	CrCbGaD
Promethazine—Thioproperazine—SLC22A1—hematologic cancer	0.000186	0.0911	CrCbGaD
Promethazine—Pipotiazine—SLC22A1—hematologic cancer	0.000183	0.0896	CrCbGaD
Promethazine—ABCB1—lymph node—hematologic cancer	0.000162	0.00402	CbGeAlD
Promethazine—Clomipramine—GSTP1—hematologic cancer	0.000156	0.0766	CrCbGaD
Promethazine—Diphenhydramine—SLC22A1—hematologic cancer	0.000131	0.064	CrCbGaD
Promethazine—Desipramine—SLC22A1—hematologic cancer	0.000116	0.057	CrCbGaD
Promethazine—Chlorpromazine—SLC22A1—hematologic cancer	9.91e-05	0.0486	CrCbGaD
Promethazine—Imipramine—SLC22A1—hematologic cancer	9.86e-05	0.0483	CrCbGaD
Promethazine—Oxcarbazepine—ALB—hematologic cancer	7.67e-05	0.0376	CrCbGaD
Promethazine—Diltiazem—ABCB1—hematologic cancer	6.7e-05	0.0329	CrCbGaD
Promethazine—Asthenia—Vincristine—hematologic cancer	6.61e-05	0.000295	CcSEcCtD
Promethazine—Tachycardia—Triamcinolone—hematologic cancer	6.61e-05	0.000295	CcSEcCtD
Promethazine—Diarrhoea—Carmustine—hematologic cancer	6.6e-05	0.000294	CcSEcCtD
Promethazine—Drowsiness—Epirubicin—hematologic cancer	6.56e-05	0.000292	CcSEcCtD
Promethazine—Erythema—Prednisone—hematologic cancer	6.55e-05	0.000292	CcSEcCtD
Promethazine—Rash—Thiotepa—hematologic cancer	6.55e-05	0.000292	CcSEcCtD
Promethazine—Dermatitis—Thiotepa—hematologic cancer	6.54e-05	0.000292	CcSEcCtD
Promethazine—Diarrhoea—Alitretinoin—hematologic cancer	6.54e-05	0.000292	CcSEcCtD
Promethazine—Agranulocytosis—Methotrexate—hematologic cancer	6.54e-05	0.000292	CcSEcCtD
Promethazine—Convulsion—Dexamethasone—hematologic cancer	6.52e-05	0.000291	CcSEcCtD
Promethazine—Convulsion—Betamethasone—hematologic cancer	6.52e-05	0.000291	CcSEcCtD
Promethazine—Headache—Thiotepa—hematologic cancer	6.51e-05	0.00029	CcSEcCtD
Promethazine—Decreased appetite—Etoposide—hematologic cancer	6.49e-05	0.000289	CcSEcCtD
Promethazine—Diarrhoea—Ifosfamide—hematologic cancer	6.46e-05	0.000288	CcSEcCtD
Promethazine—Asthenia—Mitoxantrone—hematologic cancer	6.44e-05	0.000287	CcSEcCtD
Promethazine—Asthenia—Irinotecan—hematologic cancer	6.44e-05	0.000287	CcSEcCtD
Promethazine—Fatigue—Etoposide—hematologic cancer	6.43e-05	0.000287	CcSEcCtD
Promethazine—Jaundice—Epirubicin—hematologic cancer	6.39e-05	0.000285	CcSEcCtD
Promethazine—Anxiety—Dexamethasone—hematologic cancer	6.38e-05	0.000285	CcSEcCtD
Promethazine—Anxiety—Betamethasone—hematologic cancer	6.38e-05	0.000285	CcSEcCtD
Promethazine—Dizziness—Carmustine—hematologic cancer	6.38e-05	0.000285	CcSEcCtD
Promethazine—Pain—Etoposide—hematologic cancer	6.38e-05	0.000285	CcSEcCtD
Promethazine—Constipation—Etoposide—hematologic cancer	6.38e-05	0.000285	CcSEcCtD
Promethazine—Rash—Thalidomide—hematologic cancer	6.34e-05	0.000283	CcSEcCtD
Promethazine—Dermatitis—Thalidomide—hematologic cancer	6.33e-05	0.000282	CcSEcCtD
Promethazine—Dizziness—Alitretinoin—hematologic cancer	6.32e-05	0.000282	CcSEcCtD
Promethazine—Diarrhoea—Vincristine—hematologic cancer	6.3e-05	0.000281	CcSEcCtD
Promethazine—Headache—Thalidomide—hematologic cancer	6.29e-05	0.000281	CcSEcCtD
Promethazine—Pain—Prednisolone—hematologic cancer	6.29e-05	0.000281	CcSEcCtD
Promethazine—Asthenia—Gemcitabine—hematologic cancer	6.27e-05	0.00028	CcSEcCtD
Promethazine—Dizziness—Ifosfamide—hematologic cancer	6.25e-05	0.000279	CcSEcCtD
Promethazine—Photosensitivity reaction—Doxorubicin—hematologic cancer	6.21e-05	0.000277	CcSEcCtD
Promethazine—Pruritus—Gemcitabine—hematologic cancer	6.18e-05	0.000276	CcSEcCtD
Promethazine—Vision blurred—Prednisone—hematologic cancer	6.18e-05	0.000275	CcSEcCtD
Promethazine—Feeling abnormal—Etoposide—hematologic cancer	6.15e-05	0.000274	CcSEcCtD
Promethazine—Oedema—Dexamethasone—hematologic cancer	6.14e-05	0.000274	CcSEcCtD
Promethazine—Anaphylactic shock—Dexamethasone—hematologic cancer	6.14e-05	0.000274	CcSEcCtD
Promethazine—Anaphylactic shock—Betamethasone—hematologic cancer	6.14e-05	0.000274	CcSEcCtD
Promethazine—Oedema—Betamethasone—hematologic cancer	6.14e-05	0.000274	CcSEcCtD
Promethazine—Diarrhoea—Mitoxantrone—hematologic cancer	6.14e-05	0.000274	CcSEcCtD
Promethazine—Diarrhoea—Irinotecan—hematologic cancer	6.14e-05	0.000274	CcSEcCtD
Promethazine—Insomnia—Triamcinolone—hematologic cancer	6.12e-05	0.000273	CcSEcCtD
Promethazine—Agranulocytosis—Epirubicin—hematologic cancer	6.12e-05	0.000273	CcSEcCtD
Promethazine—Dizziness—Vincristine—hematologic cancer	6.09e-05	0.000272	CcSEcCtD
Promethazine—Rash—Carmustine—hematologic cancer	6.08e-05	0.000271	CcSEcCtD
Promethazine—Dermatitis—Carmustine—hematologic cancer	6.08e-05	0.000271	CcSEcCtD
Promethazine—Drowsiness—Doxorubicin—hematologic cancer	6.07e-05	0.000271	CcSEcCtD
Promethazine—Feeling abnormal—Prednisolone—hematologic cancer	6.06e-05	0.00027	CcSEcCtD
Promethazine—Headache—Carmustine—hematologic cancer	6.05e-05	0.00027	CcSEcCtD
Promethazine—Shock—Betamethasone—hematologic cancer	6.04e-05	0.000269	CcSEcCtD
Promethazine—Shock—Dexamethasone—hematologic cancer	6.04e-05	0.000269	CcSEcCtD
Promethazine—Rash—Alitretinoin—hematologic cancer	6.03e-05	0.000269	CcSEcCtD
Promethazine—Agitation—Prednisone—hematologic cancer	6.02e-05	0.000269	CcSEcCtD
Promethazine—Dermatitis—Alitretinoin—hematologic cancer	6.02e-05	0.000269	CcSEcCtD
Promethazine—Thrombocytopenia—Dexamethasone—hematologic cancer	6.01e-05	0.000268	CcSEcCtD
Promethazine—Thrombocytopenia—Betamethasone—hematologic cancer	6.01e-05	0.000268	CcSEcCtD
Promethazine—Tachycardia—Betamethasone—hematologic cancer	5.99e-05	0.000267	CcSEcCtD
Promethazine—Tachycardia—Dexamethasone—hematologic cancer	5.99e-05	0.000267	CcSEcCtD
Promethazine—Bradycardia—Epirubicin—hematologic cancer	5.99e-05	0.000267	CcSEcCtD
Promethazine—Headache—Alitretinoin—hematologic cancer	5.99e-05	0.000267	CcSEcCtD
Promethazine—Diarrhoea—Gemcitabine—hematologic cancer	5.98e-05	0.000267	CcSEcCtD
Promethazine—Triflupromazine—ABCB1—hematologic cancer	5.98e-05	0.0293	CrCbGaD
Promethazine—Dyspepsia—Triamcinolone—hematologic cancer	5.96e-05	0.000266	CcSEcCtD
Promethazine—Rash—Ifosfamide—hematologic cancer	5.96e-05	0.000266	CcSEcCtD
Promethazine—Dermatitis—Ifosfamide—hematologic cancer	5.95e-05	0.000265	CcSEcCtD
Promethazine—Dizziness—Irinotecan—hematologic cancer	5.93e-05	0.000265	CcSEcCtD
Promethazine—Jaundice—Doxorubicin—hematologic cancer	5.92e-05	0.000264	CcSEcCtD
Promethazine—Syncope—Prednisone—hematologic cancer	5.88e-05	0.000262	CcSEcCtD
Promethazine—Tinnitus—Methotrexate—hematologic cancer	5.87e-05	0.000262	CcSEcCtD
Promethazine—Asthenia—Cisplatin—hematologic cancer	5.84e-05	0.000261	CcSEcCtD
Promethazine—Fatigue—Triamcinolone—hematologic cancer	5.84e-05	0.00026	CcSEcCtD
Promethazine—Rash—Vincristine—hematologic cancer	5.81e-05	0.000259	CcSEcCtD
Promethazine—Dermatitis—Vincristine—hematologic cancer	5.8e-05	0.000259	CcSEcCtD
Promethazine—Acepromazine—ALB—hematologic cancer	5.79e-05	0.0284	CrCbGaD
Promethazine—Pain—Triamcinolone—hematologic cancer	5.79e-05	0.000258	CcSEcCtD
Promethazine—Headache—Vincristine—hematologic cancer	5.77e-05	0.000257	CcSEcCtD
Promethazine—Loss of consciousness—Prednisone—hematologic cancer	5.76e-05	0.000257	CcSEcCtD
Promethazine—Hypotension—Betamethasone—hematologic cancer	5.74e-05	0.000256	CcSEcCtD
Promethazine—Hypotension—Dexamethasone—hematologic cancer	5.74e-05	0.000256	CcSEcCtD
Promethazine—Convulsion—Prednisone—hematologic cancer	5.68e-05	0.000253	CcSEcCtD
Promethazine—Agranulocytosis—Doxorubicin—hematologic cancer	5.66e-05	0.000253	CcSEcCtD
Promethazine—Thioproperazine—ALB—hematologic cancer	5.66e-05	0.0278	CrCbGaD
Promethazine—Rash—Mitoxantrone—hematologic cancer	5.66e-05	0.000252	CcSEcCtD
Promethazine—Rash—Irinotecan—hematologic cancer	5.66e-05	0.000252	CcSEcCtD
Promethazine—Dermatitis—Mitoxantrone—hematologic cancer	5.65e-05	0.000252	CcSEcCtD
Promethazine—Dermatitis—Irinotecan—hematologic cancer	5.65e-05	0.000252	CcSEcCtD
Promethazine—Headache—Irinotecan—hematologic cancer	5.62e-05	0.000251	CcSEcCtD
Promethazine—Headache—Mitoxantrone—hematologic cancer	5.62e-05	0.000251	CcSEcCtD
Promethazine—Feeling abnormal—Triamcinolone—hematologic cancer	5.58e-05	0.000249	CcSEcCtD
Promethazine—Diarrhoea—Cisplatin—hematologic cancer	5.57e-05	0.000249	CcSEcCtD
Promethazine—Pipotiazine—ALB—hematologic cancer	5.57e-05	0.0273	CrCbGaD
Promethazine—Anxiety—Prednisone—hematologic cancer	5.56e-05	0.000248	CcSEcCtD
Promethazine—Insomnia—Betamethasone—hematologic cancer	5.55e-05	0.000248	CcSEcCtD
Promethazine—Insomnia—Dexamethasone—hematologic cancer	5.55e-05	0.000248	CcSEcCtD
Promethazine—Bradycardia—Doxorubicin—hematologic cancer	5.55e-05	0.000247	CcSEcCtD
Promethazine—Rash—Gemcitabine—hematologic cancer	5.51e-05	0.000246	CcSEcCtD
Promethazine—Dermatitis—Gemcitabine—hematologic cancer	5.5e-05	0.000245	CcSEcCtD
Promethazine—Tinnitus—Epirubicin—hematologic cancer	5.49e-05	0.000245	CcSEcCtD
Promethazine—Erythema—Methotrexate—hematologic cancer	5.48e-05	0.000244	CcSEcCtD
Promethazine—Headache—Gemcitabine—hematologic cancer	5.47e-05	0.000244	CcSEcCtD
Promethazine—Dyspepsia—Betamethasone—hematologic cancer	5.41e-05	0.000241	CcSEcCtD
Promethazine—Dyspepsia—Dexamethasone—hematologic cancer	5.41e-05	0.000241	CcSEcCtD
Promethazine—Asthenia—Etoposide—hematologic cancer	5.35e-05	0.000239	CcSEcCtD
Promethazine—Oedema—Prednisone—hematologic cancer	5.35e-05	0.000238	CcSEcCtD
Promethazine—Anaphylactic shock—Prednisone—hematologic cancer	5.35e-05	0.000238	CcSEcCtD
Promethazine—Decreased appetite—Dexamethasone—hematologic cancer	5.34e-05	0.000238	CcSEcCtD
Promethazine—Decreased appetite—Betamethasone—hematologic cancer	5.34e-05	0.000238	CcSEcCtD
Promethazine—Fatigue—Dexamethasone—hematologic cancer	5.29e-05	0.000236	CcSEcCtD
Promethazine—Fatigue—Betamethasone—hematologic cancer	5.29e-05	0.000236	CcSEcCtD
Promethazine—Pruritus—Etoposide—hematologic cancer	5.28e-05	0.000235	CcSEcCtD
Promethazine—Shock—Prednisone—hematologic cancer	5.26e-05	0.000235	CcSEcCtD
Promethazine—Arrhythmia—Epirubicin—hematologic cancer	5.26e-05	0.000235	CcSEcCtD
Promethazine—Pain—Betamethasone—hematologic cancer	5.25e-05	0.000234	CcSEcCtD
Promethazine—Pain—Dexamethasone—hematologic cancer	5.25e-05	0.000234	CcSEcCtD
Promethazine—Tachycardia—Prednisone—hematologic cancer	5.22e-05	0.000233	CcSEcCtD
Promethazine—Vision blurred—Methotrexate—hematologic cancer	5.16e-05	0.00023	CcSEcCtD
Promethazine—Rash—Cisplatin—hematologic cancer	5.14e-05	0.000229	CcSEcCtD
Promethazine—Dermatitis—Cisplatin—hematologic cancer	5.13e-05	0.000229	CcSEcCtD
Promethazine—Erythema—Epirubicin—hematologic cancer	5.13e-05	0.000229	CcSEcCtD
Promethazine—Diarrhoea—Etoposide—hematologic cancer	5.11e-05	0.000228	CcSEcCtD
Promethazine—Tinnitus—Doxorubicin—hematologic cancer	5.08e-05	0.000227	CcSEcCtD
Promethazine—Feeling abnormal—Dexamethasone—hematologic cancer	5.06e-05	0.000226	CcSEcCtD
Promethazine—Feeling abnormal—Betamethasone—hematologic cancer	5.06e-05	0.000226	CcSEcCtD
Promethazine—Tension—Epirubicin—hematologic cancer	5.03e-05	0.000224	CcSEcCtD
Promethazine—Carbamazepine—ABCB1—hematologic cancer	4.99e-05	0.0244	CrCbGaD
Promethazine—Nervousness—Epirubicin—hematologic cancer	4.98e-05	0.000222	CcSEcCtD
Promethazine—Dizziness—Etoposide—hematologic cancer	4.93e-05	0.00022	CcSEcCtD
Promethazine—Muscle spasms—Epirubicin—hematologic cancer	4.93e-05	0.00022	CcSEcCtD
Promethazine—Leukopenia—Methotrexate—hematologic cancer	4.9e-05	0.000219	CcSEcCtD
Promethazine—Dizziness—Prednisolone—hematologic cancer	4.87e-05	0.000217	CcSEcCtD
Promethazine—Arrhythmia—Doxorubicin—hematologic cancer	4.87e-05	0.000217	CcSEcCtD
Promethazine—Asthenia—Triamcinolone—hematologic cancer	4.86e-05	0.000217	CcSEcCtD
Promethazine—Insomnia—Prednisone—hematologic cancer	4.84e-05	0.000216	CcSEcCtD
Promethazine—Vision blurred—Epirubicin—hematologic cancer	4.83e-05	0.000215	CcSEcCtD
Promethazine—Pruritus—Triamcinolone—hematologic cancer	4.79e-05	0.000214	CcSEcCtD
Promethazine—Convulsion—Methotrexate—hematologic cancer	4.75e-05	0.000212	CcSEcCtD
Promethazine—Erythema—Doxorubicin—hematologic cancer	4.74e-05	0.000211	CcSEcCtD
Promethazine—Agitation—Epirubicin—hematologic cancer	4.71e-05	0.00021	CcSEcCtD
Promethazine—Dyspepsia—Prednisone—hematologic cancer	4.71e-05	0.00021	CcSEcCtD
Promethazine—Rash—Etoposide—hematologic cancer	4.7e-05	0.00021	CcSEcCtD
Promethazine—Dermatitis—Etoposide—hematologic cancer	4.7e-05	0.00021	CcSEcCtD
Promethazine—Headache—Etoposide—hematologic cancer	4.67e-05	0.000208	CcSEcCtD
Promethazine—Tension—Doxorubicin—hematologic cancer	4.65e-05	0.000208	CcSEcCtD
Promethazine—Decreased appetite—Prednisone—hematologic cancer	4.65e-05	0.000207	CcSEcCtD
Promethazine—Rash—Prednisolone—hematologic cancer	4.64e-05	0.000207	CcSEcCtD
Promethazine—Dermatitis—Prednisolone—hematologic cancer	4.64e-05	0.000207	CcSEcCtD
Promethazine—Fatigue—Prednisone—hematologic cancer	4.61e-05	0.000206	CcSEcCtD
Promethazine—Headache—Prednisolone—hematologic cancer	4.61e-05	0.000206	CcSEcCtD
Promethazine—Nervousness—Doxorubicin—hematologic cancer	4.61e-05	0.000205	CcSEcCtD
Promethazine—Syncope—Epirubicin—hematologic cancer	4.6e-05	0.000205	CcSEcCtD
Promethazine—Leukopenia—Epirubicin—hematologic cancer	4.59e-05	0.000205	CcSEcCtD
Promethazine—Constipation—Prednisone—hematologic cancer	4.57e-05	0.000204	CcSEcCtD
Promethazine—Muscle spasms—Doxorubicin—hematologic cancer	4.56e-05	0.000203	CcSEcCtD
Promethazine—Palpitations—Epirubicin—hematologic cancer	4.53e-05	0.000202	CcSEcCtD
Promethazine—Confusional state—Methotrexate—hematologic cancer	4.51e-05	0.000201	CcSEcCtD
Promethazine—Loss of consciousness—Epirubicin—hematologic cancer	4.5e-05	0.000201	CcSEcCtD
Promethazine—Dizziness—Triamcinolone—hematologic cancer	4.48e-05	0.0002	CcSEcCtD
Promethazine—Anaphylactic shock—Methotrexate—hematologic cancer	4.47e-05	0.000199	CcSEcCtD
Promethazine—Vision blurred—Doxorubicin—hematologic cancer	4.47e-05	0.000199	CcSEcCtD
Promethazine—Convulsion—Epirubicin—hematologic cancer	4.44e-05	0.000198	CcSEcCtD
Promethazine—Feeling abnormal—Prednisone—hematologic cancer	4.41e-05	0.000197	CcSEcCtD
Promethazine—Asthenia—Dexamethasone—hematologic cancer	4.41e-05	0.000196	CcSEcCtD
Promethazine—Asthenia—Betamethasone—hematologic cancer	4.41e-05	0.000196	CcSEcCtD
Promethazine—Clomipramine—ALB—hematologic cancer	4.4e-05	0.0216	CrCbGaD
Promethazine—Thrombocytopenia—Methotrexate—hematologic cancer	4.38e-05	0.000195	CcSEcCtD
Promethazine—Agitation—Doxorubicin—hematologic cancer	4.36e-05	0.000194	CcSEcCtD
Promethazine—Anxiety—Epirubicin—hematologic cancer	4.35e-05	0.000194	CcSEcCtD
Promethazine—Pruritus—Betamethasone—hematologic cancer	4.34e-05	0.000194	CcSEcCtD
Promethazine—Pruritus—Dexamethasone—hematologic cancer	4.34e-05	0.000194	CcSEcCtD
Promethazine—Rash—Triamcinolone—hematologic cancer	4.27e-05	0.00019	CcSEcCtD
Promethazine—Dry mouth—Epirubicin—hematologic cancer	4.27e-05	0.00019	CcSEcCtD
Promethazine—Dermatitis—Triamcinolone—hematologic cancer	4.26e-05	0.00019	CcSEcCtD
Promethazine—Syncope—Doxorubicin—hematologic cancer	4.25e-05	0.00019	CcSEcCtD
Promethazine—Leukopenia—Doxorubicin—hematologic cancer	4.24e-05	0.000189	CcSEcCtD
Promethazine—Headache—Triamcinolone—hematologic cancer	4.24e-05	0.000189	CcSEcCtD
Promethazine—Confusional state—Epirubicin—hematologic cancer	4.22e-05	0.000188	CcSEcCtD
Promethazine—Clomipramine—ABCB1—hematologic cancer	4.2e-05	0.0206	CrCbGaD
Promethazine—Diarrhoea—Betamethasone—hematologic cancer	4.2e-05	0.000187	CcSEcCtD
Promethazine—Diarrhoea—Dexamethasone—hematologic cancer	4.2e-05	0.000187	CcSEcCtD
Promethazine—Palpitations—Doxorubicin—hematologic cancer	4.19e-05	0.000187	CcSEcCtD
Promethazine—Chlorprothixene—ABCB1—hematologic cancer	4.18e-05	0.0205	CrCbGaD
Promethazine—Anaphylactic shock—Epirubicin—hematologic cancer	4.18e-05	0.000187	CcSEcCtD
Promethazine—Oedema—Epirubicin—hematologic cancer	4.18e-05	0.000187	CcSEcCtD
Promethazine—Hypotension—Methotrexate—hematologic cancer	4.18e-05	0.000186	CcSEcCtD
Promethazine—Loss of consciousness—Doxorubicin—hematologic cancer	4.17e-05	0.000186	CcSEcCtD
Promethazine—Shock—Epirubicin—hematologic cancer	4.12e-05	0.000184	CcSEcCtD
Promethazine—Convulsion—Doxorubicin—hematologic cancer	4.11e-05	0.000183	CcSEcCtD
Promethazine—Thrombocytopenia—Epirubicin—hematologic cancer	4.1e-05	0.000183	CcSEcCtD
Promethazine—Tachycardia—Epirubicin—hematologic cancer	4.08e-05	0.000182	CcSEcCtD
Promethazine—Dizziness—Betamethasone—hematologic cancer	4.06e-05	0.000181	CcSEcCtD
Promethazine—Dizziness—Dexamethasone—hematologic cancer	4.06e-05	0.000181	CcSEcCtD
Promethazine—Insomnia—Methotrexate—hematologic cancer	4.04e-05	0.00018	CcSEcCtD
Promethazine—Anxiety—Doxorubicin—hematologic cancer	4.02e-05	0.000179	CcSEcCtD
Promethazine—Somnolence—Methotrexate—hematologic cancer	3.97e-05	0.000177	CcSEcCtD
Promethazine—Dry mouth—Doxorubicin—hematologic cancer	3.95e-05	0.000176	CcSEcCtD
Promethazine—Dyspepsia—Methotrexate—hematologic cancer	3.93e-05	0.000175	CcSEcCtD
Promethazine—Hypotension—Epirubicin—hematologic cancer	3.91e-05	0.000174	CcSEcCtD
Promethazine—Confusional state—Doxorubicin—hematologic cancer	3.9e-05	0.000174	CcSEcCtD
Promethazine—Decreased appetite—Methotrexate—hematologic cancer	3.89e-05	0.000173	CcSEcCtD
Promethazine—Rash—Dexamethasone—hematologic cancer	3.87e-05	0.000173	CcSEcCtD
Promethazine—Rash—Betamethasone—hematologic cancer	3.87e-05	0.000173	CcSEcCtD
Promethazine—Oedema—Doxorubicin—hematologic cancer	3.87e-05	0.000173	CcSEcCtD
Promethazine—Anaphylactic shock—Doxorubicin—hematologic cancer	3.87e-05	0.000173	CcSEcCtD
Promethazine—Dermatitis—Dexamethasone—hematologic cancer	3.87e-05	0.000173	CcSEcCtD
Promethazine—Dermatitis—Betamethasone—hematologic cancer	3.87e-05	0.000173	CcSEcCtD
Promethazine—Trimipramine—ABCB1—hematologic cancer	3.87e-05	0.019	CrCbGaD
Promethazine—Fatigue—Methotrexate—hematologic cancer	3.85e-05	0.000172	CcSEcCtD
Promethazine—Headache—Dexamethasone—hematologic cancer	3.85e-05	0.000172	CcSEcCtD
Promethazine—Headache—Betamethasone—hematologic cancer	3.85e-05	0.000172	CcSEcCtD
Promethazine—Asthenia—Prednisone—hematologic cancer	3.84e-05	0.000171	CcSEcCtD
Promethazine—Pain—Methotrexate—hematologic cancer	3.82e-05	0.00017	CcSEcCtD
Promethazine—Shock—Doxorubicin—hematologic cancer	3.81e-05	0.00017	CcSEcCtD
Promethazine—Thrombocytopenia—Doxorubicin—hematologic cancer	3.79e-05	0.000169	CcSEcCtD
Promethazine—Pruritus—Prednisone—hematologic cancer	3.78e-05	0.000169	CcSEcCtD
Promethazine—Insomnia—Epirubicin—hematologic cancer	3.78e-05	0.000169	CcSEcCtD
Promethazine—Tachycardia—Doxorubicin—hematologic cancer	3.78e-05	0.000168	CcSEcCtD
Promethazine—Somnolence—Epirubicin—hematologic cancer	3.72e-05	0.000166	CcSEcCtD
Promethazine—Doxepin—ABCB1—hematologic cancer	3.68e-05	0.0181	CrCbGaD
Promethazine—Feeling abnormal—Methotrexate—hematologic cancer	3.68e-05	0.000164	CcSEcCtD
Promethazine—Dyspepsia—Epirubicin—hematologic cancer	3.68e-05	0.000164	CcSEcCtD
Promethazine—Trifluoperazine—ABCB1—hematologic cancer	3.67e-05	0.018	CrCbGaD
Promethazine—Methadone—ABCB1—hematologic cancer	3.67e-05	0.018	CrCbGaD
Promethazine—Diarrhoea—Prednisone—hematologic cancer	3.66e-05	0.000163	CcSEcCtD
Promethazine—Decreased appetite—Epirubicin—hematologic cancer	3.64e-05	0.000162	CcSEcCtD
Promethazine—Hypotension—Doxorubicin—hematologic cancer	3.62e-05	0.000161	CcSEcCtD
Promethazine—Fatigue—Epirubicin—hematologic cancer	3.61e-05	0.000161	CcSEcCtD
Promethazine—Constipation—Epirubicin—hematologic cancer	3.58e-05	0.00016	CcSEcCtD
Promethazine—Pain—Epirubicin—hematologic cancer	3.58e-05	0.00016	CcSEcCtD
Promethazine—Dizziness—Prednisone—hematologic cancer	3.54e-05	0.000158	CcSEcCtD
Promethazine—Insomnia—Doxorubicin—hematologic cancer	3.5e-05	0.000156	CcSEcCtD
Promethazine—Feeling abnormal—Epirubicin—hematologic cancer	3.45e-05	0.000154	CcSEcCtD
Promethazine—Somnolence—Doxorubicin—hematologic cancer	3.44e-05	0.000153	CcSEcCtD
Promethazine—Dyspepsia—Doxorubicin—hematologic cancer	3.41e-05	0.000152	CcSEcCtD
Promethazine—Desipramine—ABCB1—hematologic cancer	3.38e-05	0.0166	CrCbGaD
Promethazine—Rash—Prednisone—hematologic cancer	3.37e-05	0.00015	CcSEcCtD
Promethazine—Dermatitis—Prednisone—hematologic cancer	3.37e-05	0.00015	CcSEcCtD
Promethazine—Decreased appetite—Doxorubicin—hematologic cancer	3.36e-05	0.00015	CcSEcCtD
Promethazine—Headache—Prednisone—hematologic cancer	3.35e-05	0.000149	CcSEcCtD
Promethazine—Fatigue—Doxorubicin—hematologic cancer	3.34e-05	0.000149	CcSEcCtD
Promethazine—Constipation—Doxorubicin—hematologic cancer	3.31e-05	0.000148	CcSEcCtD
Promethazine—Pain—Doxorubicin—hematologic cancer	3.31e-05	0.000148	CcSEcCtD
Promethazine—Asthenia—Methotrexate—hematologic cancer	3.21e-05	0.000143	CcSEcCtD
Promethazine—Feeling abnormal—Doxorubicin—hematologic cancer	3.19e-05	0.000142	CcSEcCtD
Promethazine—Pruritus—Methotrexate—hematologic cancer	3.16e-05	0.000141	CcSEcCtD
Promethazine—Diarrhoea—Methotrexate—hematologic cancer	3.06e-05	0.000136	CcSEcCtD
Promethazine—Chlorpromazine—ALB—hematologic cancer	3.02e-05	0.0148	CrCbGaD
Promethazine—Asthenia—Epirubicin—hematologic cancer	3e-05	0.000134	CcSEcCtD
Promethazine—Amitriptyline—ALB—hematologic cancer	2.99e-05	0.0146	CrCbGaD
Promethazine—Pruritus—Epirubicin—hematologic cancer	2.96e-05	0.000132	CcSEcCtD
Promethazine—Dizziness—Methotrexate—hematologic cancer	2.96e-05	0.000132	CcSEcCtD
Promethazine—Chlorpromazine—ABCB1—hematologic cancer	2.88e-05	0.0141	CrCbGaD
Promethazine—Imipramine—ABCB1—hematologic cancer	2.87e-05	0.0141	CrCbGaD
Promethazine—Diarrhoea—Epirubicin—hematologic cancer	2.86e-05	0.000128	CcSEcCtD
Promethazine—Amitriptyline—ABCB1—hematologic cancer	2.85e-05	0.014	CrCbGaD
Promethazine—Rash—Methotrexate—hematologic cancer	2.82e-05	0.000126	CcSEcCtD
Promethazine—Dermatitis—Methotrexate—hematologic cancer	2.82e-05	0.000126	CcSEcCtD
Promethazine—Headache—Methotrexate—hematologic cancer	2.8e-05	0.000125	CcSEcCtD
Promethazine—Asthenia—Doxorubicin—hematologic cancer	2.78e-05	0.000124	CcSEcCtD
Promethazine—Dizziness—Epirubicin—hematologic cancer	2.77e-05	0.000123	CcSEcCtD
Promethazine—Pruritus—Doxorubicin—hematologic cancer	2.74e-05	0.000122	CcSEcCtD
Promethazine—Diarrhoea—Doxorubicin—hematologic cancer	2.65e-05	0.000118	CcSEcCtD
Promethazine—Rash—Epirubicin—hematologic cancer	2.64e-05	0.000118	CcSEcCtD
Promethazine—Dermatitis—Epirubicin—hematologic cancer	2.63e-05	0.000118	CcSEcCtD
Promethazine—Headache—Epirubicin—hematologic cancer	2.62e-05	0.000117	CcSEcCtD
Promethazine—Dizziness—Doxorubicin—hematologic cancer	2.56e-05	0.000114	CcSEcCtD
Promethazine—Rash—Doxorubicin—hematologic cancer	2.44e-05	0.000109	CcSEcCtD
Promethazine—Dermatitis—Doxorubicin—hematologic cancer	2.44e-05	0.000109	CcSEcCtD
Promethazine—Headache—Doxorubicin—hematologic cancer	2.42e-05	0.000108	CcSEcCtD
Promethazine—CALM1—Signaling Pathways—MDM2—hematologic cancer	1.47e-06	8.09e-06	CbGpPWpGaD
Promethazine—CALM1—Immune System—KRAS—hematologic cancer	1.47e-06	8.08e-06	CbGpPWpGaD
Promethazine—CALM2—Immune System—KRAS—hematologic cancer	1.47e-06	8.08e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EP300—hematologic cancer	1.47e-06	8.08e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—MYC—hematologic cancer	1.47e-06	8.07e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—MYC—hematologic cancer	1.47e-06	8.07e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EP300—hematologic cancer	1.47e-06	8.06e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—TGFB1—hematologic cancer	1.47e-06	8.06e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—TGFB1—hematologic cancer	1.47e-06	8.06e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EP300—hematologic cancer	1.46e-06	8.04e-06	CbGpPWpGaD
Promethazine—CALM3—Metabolism—EP300—hematologic cancer	1.46e-06	8.02e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EP300—hematologic cancer	1.46e-06	8.01e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.46e-06	7.99e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—SRC—hematologic cancer	1.45e-06	7.99e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.45e-06	7.98e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EP300—hematologic cancer	1.45e-06	7.93e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	1.44e-06	7.91e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.44e-06	7.91e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PIK3CB—hematologic cancer	1.43e-06	7.87e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PIK3CB—hematologic cancer	1.43e-06	7.87e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MTOR—hematologic cancer	1.43e-06	7.87e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MTOR—hematologic cancer	1.43e-06	7.87e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—ALB—hematologic cancer	1.43e-06	7.87e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—SRC—hematologic cancer	1.43e-06	7.86e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—SRC—hematologic cancer	1.43e-06	7.84e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—SRC—hematologic cancer	1.42e-06	7.82e-06	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—HRAS—hematologic cancer	1.42e-06	7.81e-06	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IL6—hematologic cancer	1.42e-06	7.81e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—ALB—hematologic cancer	1.42e-06	7.81e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—SRC—hematologic cancer	1.42e-06	7.79e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.42e-06	7.78e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—HRAS—hematologic cancer	1.42e-06	7.77e-06	CbGpPWpGaD
Promethazine—CALM2—Metabolism—EP300—hematologic cancer	1.41e-06	7.76e-06	CbGpPWpGaD
Promethazine—CALM1—Metabolism—EP300—hematologic cancer	1.41e-06	7.76e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—SRC—hematologic cancer	1.41e-06	7.72e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—KRAS—hematologic cancer	1.4e-06	7.71e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.4e-06	7.7e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	1.4e-06	7.69e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.4e-06	7.68e-06	CbGpPWpGaD
Promethazine—CALM3—Immune System—PIK3CA—hematologic cancer	1.4e-06	7.68e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	1.39e-06	7.65e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CDKN1B—hematologic cancer	1.39e-06	7.64e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	1.39e-06	7.64e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	1.39e-06	7.61e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	1.38e-06	7.59e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—STAT3—hematologic cancer	1.38e-06	7.58e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.38e-06	7.56e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—NRAS—hematologic cancer	1.38e-06	7.56e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.37e-06	7.54e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—STAT3—hematologic cancer	1.37e-06	7.54e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.37e-06	7.53e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—NRAS—hematologic cancer	1.37e-06	7.52e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—HRAS—hematologic cancer	1.37e-06	7.52e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—HRAS—hematologic cancer	1.37e-06	7.52e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	1.37e-06	7.51e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—STAT3—hematologic cancer	1.37e-06	7.51e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—NRAS—hematologic cancer	1.37e-06	7.5e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	1.37e-06	7.49e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CASP3—hematologic cancer	1.36e-06	7.49e-06	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IL6—hematologic cancer	1.36e-06	7.48e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL2—hematologic cancer	1.36e-06	7.48e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.36e-06	7.47e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—KRAS—hematologic cancer	1.36e-06	7.46e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—KRAS—hematologic cancer	1.36e-06	7.46e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	1.36e-06	7.44e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—IL6—hematologic cancer	1.35e-06	7.44e-06	CbGpPWpGaD
Promethazine—CALM1—Immune System—PIK3CA—hematologic cancer	1.35e-06	7.42e-06	CbGpPWpGaD
Promethazine—CALM2—Immune System—PIK3CA—hematologic cancer	1.35e-06	7.42e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	1.35e-06	7.42e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	1.35e-06	7.42e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	1.35e-06	7.4e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CDKN1B—hematologic cancer	1.35e-06	7.39e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CDKN1B—hematologic cancer	1.35e-06	7.39e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.34e-06	7.38e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.34e-06	7.36e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCND1—hematologic cancer	1.33e-06	7.29e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—JUN—hematologic cancer	1.32e-06	7.27e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CASP3—hematologic cancer	1.32e-06	7.24e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CASP3—hematologic cancer	1.32e-06	7.24e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	1.32e-06	7.24e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL2—hematologic cancer	1.32e-06	7.23e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL2—hematologic cancer	1.32e-06	7.23e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	1.32e-06	7.22e-06	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—AKT1—hematologic cancer	1.31e-06	7.2e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	1.31e-06	7.2e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—IL6—hematologic cancer	1.31e-06	7.2e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—IL6—hematologic cancer	1.31e-06	7.2e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	1.31e-06	7.18e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MYC—hematologic cancer	1.3e-06	7.16e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.3e-06	7.14e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	1.29e-06	7.11e-06	CbGpPWpGaD
Promethazine—CALM3—Immune System—HRAS—hematologic cancer	1.29e-06	7.1e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	1.29e-06	7.09e-06	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—PIK3CA—hematologic cancer	1.29e-06	7.09e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—PIK3CA—hematologic cancer	1.29e-06	7.09e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CDKN1A—hematologic cancer	1.28e-06	7.05e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCND1—hematologic cancer	1.28e-06	7.05e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCND1—hematologic cancer	1.28e-06	7.05e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MYC—hematologic cancer	1.28e-06	7.04e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—JUN—hematologic cancer	1.28e-06	7.03e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—JUN—hematologic cancer	1.28e-06	7.03e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PTEN—hematologic cancer	1.28e-06	7.03e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MYC—hematologic cancer	1.28e-06	7.03e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	1.28e-06	7.02e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	1.28e-06	7.01e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MYC—hematologic cancer	1.28e-06	7e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	1.27e-06	6.99e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MYC—hematologic cancer	1.27e-06	6.98e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	1.27e-06	6.96e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.27e-06	6.95e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MYC—hematologic cancer	1.26e-06	6.91e-06	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—AKT1—hematologic cancer	1.26e-06	6.9e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	1.26e-06	6.9e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	1.26e-06	6.9e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.26e-06	6.89e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MAPK8—hematologic cancer	1.25e-06	6.88e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	1.25e-06	6.88e-06	CbGpPWpGaD
Promethazine—CALM1—Immune System—HRAS—hematologic cancer	1.25e-06	6.87e-06	CbGpPWpGaD
Promethazine—CALM2—Immune System—HRAS—hematologic cancer	1.25e-06	6.87e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—AKT1—hematologic cancer	1.25e-06	6.86e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—PIK3CA—hematologic cancer	1.25e-06	6.85e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—PIK3CA—hematologic cancer	1.25e-06	6.85e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CDKN1A—hematologic cancer	1.24e-06	6.82e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CDKN1A—hematologic cancer	1.24e-06	6.82e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PTEN—hematologic cancer	1.24e-06	6.8e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PTEN—hematologic cancer	1.24e-06	6.8e-06	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL6—hematologic cancer	1.24e-06	6.8e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EP300—hematologic cancer	1.22e-06	6.71e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MAPK8—hematologic cancer	1.21e-06	6.66e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MAPK8—hematologic cancer	1.21e-06	6.66e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—AKT1—hematologic cancer	1.21e-06	6.64e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—AKT1—hematologic cancer	1.21e-06	6.64e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.2e-06	6.61e-06	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL6—hematologic cancer	1.2e-06	6.57e-06	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL6—hematologic cancer	1.2e-06	6.57e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—HRAS—hematologic cancer	1.19e-06	6.56e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—SRC—hematologic cancer	1.19e-06	6.52e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—KRAS—hematologic cancer	1.19e-06	6.51e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—KRAS—hematologic cancer	1.18e-06	6.49e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EP300—hematologic cancer	1.18e-06	6.49e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EP300—hematologic cancer	1.18e-06	6.49e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—KRAS—hematologic cancer	1.18e-06	6.47e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—KRAS—hematologic cancer	1.18e-06	6.45e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	1.16e-06	6.39e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTEN—hematologic cancer	1.16e-06	6.38e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	1.16e-06	6.37e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—VEGFA—hematologic cancer	1.16e-06	6.35e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—HRAS—hematologic cancer	1.16e-06	6.34e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—HRAS—hematologic cancer	1.16e-06	6.34e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—SRC—hematologic cancer	1.15e-06	6.31e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—SRC—hematologic cancer	1.15e-06	6.31e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—STAT3—hematologic cancer	1.15e-06	6.29e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—NRAS—hematologic cancer	1.14e-06	6.28e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—IL6—hematologic cancer	1.14e-06	6.27e-06	CbGpPWpGaD
Promethazine—CALM3—Immune System—AKT1—hematologic cancer	1.14e-06	6.27e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—VEGFA—hematologic cancer	1.12e-06	6.15e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—VEGFA—hematologic cancer	1.12e-06	6.15e-06	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.11e-06	6.1e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—STAT3—hematologic cancer	1.11e-06	6.09e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—STAT3—hematologic cancer	1.11e-06	6.09e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—EP300—hematologic cancer	1.11e-06	6.08e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	1.11e-06	6.08e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—NRAS—hematologic cancer	1.11e-06	6.07e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—NRAS—hematologic cancer	1.11e-06	6.07e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—IL6—hematologic cancer	1.11e-06	6.07e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—IL6—hematologic cancer	1.11e-06	6.07e-06	CbGpPWpGaD
Promethazine—CALM1—Immune System—AKT1—hematologic cancer	1.1e-06	6.07e-06	CbGpPWpGaD
Promethazine—CALM2—Immune System—AKT1—hematologic cancer	1.1e-06	6.07e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MAPK3—hematologic cancer	1.09e-06	6.01e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.09e-06	6.01e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	1.09e-06	5.98e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	1.09e-06	5.97e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.08e-06	5.96e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	1.08e-06	5.95e-06	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PIK3CA—hematologic cancer	1.08e-06	5.93e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	1.08e-06	5.93e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TP53—hematologic cancer	1.07e-06	5.88e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	1.07e-06	5.87e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	1.07e-06	5.85e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MYC—hematologic cancer	1.06e-06	5.85e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TGFB1—hematologic cancer	1.06e-06	5.83e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MAPK3—hematologic cancer	1.06e-06	5.81e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MAPK3—hematologic cancer	1.06e-06	5.81e-06	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—AKT1—hematologic cancer	1.05e-06	5.79e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—AKT1—hematologic cancer	1.05e-06	5.79e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TP53—hematologic cancer	1.05e-06	5.78e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TP53—hematologic cancer	1.05e-06	5.77e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TP53—hematologic cancer	1.05e-06	5.75e-06	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PIK3CA—hematologic cancer	1.05e-06	5.74e-06	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PIK3CA—hematologic cancer	1.05e-06	5.74e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TP53—hematologic cancer	1.04e-06	5.73e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—EP300—hematologic cancer	1.04e-06	5.73e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—EP300—hematologic cancer	1.03e-06	5.68e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TP53—hematologic cancer	1.03e-06	5.68e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	1.03e-06	5.66e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MYC—hematologic cancer	1.03e-06	5.65e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MYC—hematologic cancer	1.03e-06	5.65e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TGFB1—hematologic cancer	1.03e-06	5.64e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TGFB1—hematologic cancer	1.03e-06	5.64e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HRAS—hematologic cancer	1.02e-06	5.62e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—AKT1—hematologic cancer	1.02e-06	5.6e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—AKT1—hematologic cancer	1.02e-06	5.6e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—HRAS—hematologic cancer	1.01e-06	5.53e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.01e-06	5.52e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HRAS—hematologic cancer	1e-06	5.5e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HRAS—hematologic cancer	9.99e-07	5.48e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	9.89e-07	5.43e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	9.86e-07	5.42e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KRAS—hematologic cancer	9.84e-07	5.4e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL6—hematologic cancer	9.8e-07	5.38e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL6—hematologic cancer	9.64e-07	5.29e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL6—hematologic cancer	9.62e-07	5.28e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL6—hematologic cancer	9.59e-07	5.27e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL6—hematologic cancer	9.56e-07	5.25e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KRAS—hematologic cancer	9.52e-07	5.22e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KRAS—hematologic cancer	9.52e-07	5.22e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL6—hematologic cancer	9.47e-07	5.2e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	9.44e-07	5.18e-06	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—AKT1—hematologic cancer	9.07e-07	4.98e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—AKT1—hematologic cancer	9.04e-07	4.96e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PIK3CA—hematologic cancer	9.04e-07	4.96e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—AKT1—hematologic cancer	8.9e-07	4.88e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—AKT1—hematologic cancer	8.88e-07	4.87e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—AKT1—hematologic cancer	8.85e-07	4.86e-06	CbGpPWpGaD
Promethazine—CALM3—Metabolism—AKT1—hematologic cancer	8.83e-07	4.85e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—AKT1—hematologic cancer	8.82e-07	4.84e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TP53—hematologic cancer	8.74e-07	4.8e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PIK3CA—hematologic cancer	8.74e-07	4.8e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PIK3CA—hematologic cancer	8.74e-07	4.8e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	8.73e-07	4.79e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	8.71e-07	4.78e-06	CbGpPWpGaD
Promethazine—CALM2—Metabolism—AKT1—hematologic cancer	8.54e-07	4.69e-06	CbGpPWpGaD
Promethazine—CALM1—Metabolism—AKT1—hematologic cancer	8.54e-07	4.69e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TP53—hematologic cancer	8.46e-07	4.64e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TP53—hematologic cancer	8.46e-07	4.64e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HRAS—hematologic cancer	8.36e-07	4.59e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3CA—hematologic cancer	8.19e-07	4.5e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HRAS—hematologic cancer	8.09e-07	4.44e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HRAS—hematologic cancer	8.09e-07	4.44e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL6—hematologic cancer	8e-07	4.39e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL6—hematologic cancer	7.74e-07	4.25e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL6—hematologic cancer	7.74e-07	4.25e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	7.72e-07	4.24e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	7.65e-07	4.2e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—AKT1—hematologic cancer	7.38e-07	4.05e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—AKT1—hematologic cancer	7.14e-07	3.92e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—AKT1—hematologic cancer	7.14e-07	3.92e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—AKT1—hematologic cancer	6.69e-07	3.67e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—AKT1—hematologic cancer	6.31e-07	3.46e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—AKT1—hematologic cancer	6.25e-07	3.43e-06	CbGpPWpGaD
